SEC Form 4 · accession 0001179110-16-018078
Traws Pharma, Inc. · TRAW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas J McKearn
Officer — President, R&D
Period of report
Jan 26, 2016
Accepted (ET)
Jan 28, 2016 · 5:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001130598
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to purchase)F1 | $0.65 | Jan 26, 2016 | A | 71,029 | A | — | Jan 26, 2026 | common stock | 71,029 | 71,029 | D |
Explanation of responses
- F1These options vest, 25% on January 26, 2016 and 75% on December 31, 2016.